INNATE PHARMA SP.ADR/1 (IDDA) — Net Asset Momentum
INNATE PHARMA SP.ADR/1 (IDDA) recorded a net asset momentum of -345.7% as of December 2025, with net assets of €-21.70 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See INNATE PHARMA SP.ADR/1 (IDDA) liquidity interval to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
INNATE PHARMA SP.ADR/1 Net Asset Momentum (2021–2025)
This chart tracks INNATE PHARMA SP.ADR/1's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is -345.7%, with net assets of €-21.70 Million EUR as of December 2025. Read debt load of INNATE PHARMA SP.ADR/1 for a breakdown of total debt and financial obligations.
Annual Net Asset History for INNATE PHARMA SP.ADR/1 (2021–2025)
The table below shows the complete annual net asset history for INNATE PHARMA SP.ADR/1 from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market value of INNATE PHARMA SP.ADR/1.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €-21.70 Million | €62.72 Million | €84.42 Million | ▼ -345.7% |
| 2024 | €8.83 Million | €111.06 Million | €102.22 Million | ▼ -83.0% |
| 2023 | €51.90 Million | €175.19 Million | €123.29 Million | ▼ -4.2% |
| 2022 | €54.15 Million | €199.29 Million | €145.14 Million | ▼ -49.6% |
| 2021 | €107.44 Million | €267.50 Million | €160.06 Million | — |